IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)

NSE:IOLCP Revenue

IOL Chemicals and Pharmaceuticals had revenue of 7.95B INR in the quarter ending September 30, 2026, with 40.09% growth. This brings the company's total for the last twelve months to 27.51B, up 26.76% year-over-year. In the fiscal year ending March 31, 2026, IOL Chemicals and Pharmaceuticals had annual revenue of 23.19B with 11.54% growth.

• Revenue (ttm): 27.51B
• Revenue Growth: +26.76%
• P/S Ratio: 2.16
• Revenue / Employee: 8.89M
• Employees: 3,095
• Market Cap: 61.06B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Pharmaceutical 13.96B 54.2%
• Chemical 11.61B 45.0%
• Unallocated 213.80M 0.8%

By Geography

Chart

• India 17.55B 75.7%
• Rest of The World 4.65B 20.0%
• Switzerland 525.40M 2.3%
• Indonesia 471.30M 2.0%

Fiscal year ended Mar 31, 2026 See the full NSE:IOLCP breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	23.19B	2.40B	11.54%
Mar 31, 2025	20.79B	-535.80M	-2.51%
Mar 31, 2024	21.33B	-843.20M	-3.80%
Mar 31, 2023	22.17B	330.90M	1.52%
Mar 31, 2022	21.84B	2.17B	11.03%

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 10, 2026

Data Sources Report a data error